Platinum Analytics Cayman Limited Announces Pricing of Its Initial Public Offering GlobeNewswire September 19, 2025 Singapore, Sept. 19, 2025 (GLOBE NEWSWIRE) — Platinum Analytics Cayman Limited (the “Company” or “PLTS“), a software developer specializing in the provision of FX trading software development solutions, data analytics solutions and technology development solutions to financial institutions with a […]

Xcel Brands Appoints Olin Lancaster as Chief Revenue Officer GlobeNewswire September 19, 2025 NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB), a media and consumer products company known for building influential, creator-led brands, today announced the appointment of Olin C. Lancaster as Chief Revenue Officer. With more than three decades

TTM Technologies, Inc. Expands Ultra Small Radio Frequency Components Offering for Telecom, Test and Measurement, and COTS Mil-Aero Applications GlobeNewswire September 19, 2025 SANTA ANA, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology solutions, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies,

Bylvay(R) (odevixibat) approved in Japan for rare liver disease PFIC GlobeNewswire September 19, 2025 Bylvay(R) is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in Japan, offering a non-surgical treatment option for infants, young children and adults PFIC is a

Too often, the stigma surrounding prostate and urological health keeps men silent – and that silence can cost lives. Prostate cancer remains one of the most common cancers among men, and issues like urinary incontinence and erectile dysfunction continue to impact millions. Yet open conversations and early detection can make all the difference. https://mma.prnewswire.com/media/2773022/Prostate_and_Urological_Health_Campaign.pdf?p=pdfthumbnail That's

NEW YORK, NY / ACCESS Newswire / September 19, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding RxSight, Inc. (NASDAQ:RXST) class action securities lawsuit A Class Action lawsuit was filed on behalf of RxSight, Inc. investors who lost money as a result of alleged securities fraud between May 7, 2024 and July 8,

NEW YORK, NY / ACCESS Newswire / September 19, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Replimune Group, Inc. (NASDAQ:REPL) class action securities lawsuit A Class Action lawsuit was filed on behalf of Replimune Group, Inc. investors who lost money as a result of alleged securities fraud between November 22, 2024 and

(NasdaqGM:ALVO),(Nasdaq First North Iceland:ALVO),(Stockholm:ALVO SDB), REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner in Japan, Fuji Pharma Co., Ltd. (“Fuji Pharma”), has received marketing approval for three new biosimilars from

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars GlobeNewswire September 19, 2025 REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner in Japan, Fuji Pharma Co., Ltd. (“Fuji Pharma”),

NEW YORK, NY / ACCESS Newswire / September 19, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Alto Neuroscience, Inc. (NYSE:ANRO) class action securities lawsuit This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the